BOLT NASDAQ
Bolt Biotherapeutics, Inc.
1W: -3.6%
1M: -10.2%
3M: -14.0%
YTD: -40.4%
1Y: -39.0%
3Y: -82.9%
5Y: -98.7%
$3.45
-0.06 (-1.71%)
Weekly Expected Move ±9.3%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$5M
Revenue
+12.8% YoY
$-29M
Net Income
+43.3% YoY
$-32M
Free Cash Flow
+38.6% YoY
100.0%
Gross Margin
-167480.0%
Op. Margin
-154400.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-111.6%
ROA-49.6%
ROIC-138.8%
Valuation
P/E-0.2
P/B0.5
EV/EBITDA-0.4
Leverage
Debt/Equity1.71
Current Ratio2.61
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-18.22
Beneish M-46.21